Ehud Ziv

Title: **Ehud Ziv: Innovator in Pharmaceutical Compositions**

Introduction

Ehud Ziv, based in Motza Ilit, Israel, is recognized for his contributions to the field of pharmaceuticals, specifically for his innovative approaches to insulin administration. His work focuses on enhancing the bioavailability of insulin through novel compositions, making significant strides in diabetes management.

Latest Patents

Ehud Ziv holds a patent titled "Pharmaceutical compositions containing insulin." This invention provides a pharmaceutical composition suitable for the oral administration of insulin. It comprises insulin, a bile acid or its alkali metal salt, and a protease inhibitor, all encapsulated in an enterocoating to ensure the proper release of the compounds in the intestine while safely passing through the stomach. The bile acids chosen for this formulation include a range of types such as cholic acid and taurochenodeoxycholic acid, among others.

Career Highlights

Currently, Ehud Ziv is affiliated with the Hadassah Medical Organization, where his research and innovations have contributed to advancements in the treatment of diabetes. His dedication to improving patient outcomes through better medication delivery systems exemplifies his commitment to pharmaceutical science and its applications.

Collaborations

Throughout his career, Ehud has collaborated with esteemed colleagues such as Miriam Kidron and Hanoch Bar-On. Together, they work towards enhancing the effectiveness of pharmaceutical compositions and contribute to groundbreaking research that aims to improve health outcomes for patients.

Conclusion

Ehud Ziv stands out as a notable inventor in the pharmaceutical industry. His patent for oral insulin compositions represents a significant advancement in diabetes treatment, showcasing both his innovative spirit and dedication to improving patient care. With continued collaboration and research, Ziv is poised to make further contributions to the field of pharmaceuticals.